Literature DB >> 14981181

Ullrich disease due to deficiency of collagen VI in the sarcolemma.

H Ishikawa1, K Sugie, K Murayama, A Awaya, Y Suzuki, S Noguchi, Y K Hayashi, I Nonaka, I Nishino.   

Abstract

The authors identified eight patients with Ullrich disease in whom collagen VI was present in the interstitium but was absent from the sarcolemma. By electron microscopy, collagen VI in the interstitium was never linked to the basal lamina. These findings suggest that in these patients it is not the total absence of collagen VI from the muscle but the failure of collagen VI to anchor the basal lamina to the interstitium that is the cause of Ullrich disease. Only one of the patients had a mutation in the collagen VI gene, suggesting that the primary abnormality in most of the patients involved some other molecules.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14981181     DOI: 10.1212/01.wnl.0000113023.84421.00

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  23 in total

1.  Collagen VI microfibril formation is abolished by an {alpha}2(VI) von Willebrand factor type A domain mutation in a patient with Ullrich congenital muscular dystrophy.

Authors:  Leona D Tooley; Laura K Zamurs; Nicola Beecher; Naomi L Baker; Rachel A Peat; Naomi E Adams; John F Bateman; Kathryn N North; Clair Baldock; Shireen R Lamandé
Journal:  J Biol Chem       Date:  2010-08-21       Impact factor: 5.157

Review 2.  The congenital muscular dystrophies: recent advances and molecular insights.

Authors:  Jerry R Mendell; Daniel R Boué; Paul T Martin
Journal:  Pediatr Dev Pathol       Date:  2006 Nov-Dec

Review 3.  The collagen VI-related myopathies Ullrich congenital muscular dystrophy and Bethlem myopathy.

Authors:  Carsten G Bönnemann
Journal:  Handb Clin Neurol       Date:  2011

Review 4.  Collagen VI related muscle disorders.

Authors:  A K Lampe; K M D Bushby
Journal:  J Med Genet       Date:  2005-09       Impact factor: 6.318

Review 5.  Muscle MRI in pediatrics: clinical, pathological and genetic correlation.

Authors:  Claudia P Cejas; Maria M Serra; David F Gonzalez Galvez; Eliana A Cavassa; Ana L Taratuto; Gabriel A Vazquez; Mario E L Massaro; Angeles V Schteinschneider
Journal:  Pediatr Radiol       Date:  2017-01-19

6.  Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy.

Authors:  A K Lampe; D M Dunn; A C von Niederhausern; C Hamil; A Aoyagi; S H Laval; S K Marie; M-L Chu; K Swoboda; F Muntoni; C G Bonnemann; K M Flanigan; K M D Bushby; R B Weiss
Journal:  J Med Genet       Date:  2005-02       Impact factor: 6.318

7.  Novel collagen VI mutations identified in Chinese patients with Ullrich congenital muscular dystrophy.

Authors:  Yan-Zhi Zhang; Dan-Hua Zhao; Hai-Po Yang; Ai-Jie Liu; Xing-Zhi Chang; Dao-Jun Hong; Carsten Bonnemann; Yun Yuan; Xi-Ru Wu; Hui Xiong
Journal:  World J Pediatr       Date:  2014-05-07       Impact factor: 2.764

8.  Collagen VI glycine mutations: perturbed assembly and a spectrum of clinical severity.

Authors:  Rishika A Pace; Rachel A Peat; Naomi L Baker; Laura Zamurs; Matthias Mörgelin; Melita Irving; Naomi E Adams; John F Bateman; David Mowat; Nicholas J C Smith; Phillipa J Lamont; Steven A Moore; Katherine D Mathews; Kathryn N North; Shireen R Lamandé
Journal:  Ann Neurol       Date:  2008-09       Impact factor: 10.422

9.  Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines.

Authors:  Tewarit Sarachana; Rulun Zhou; Guang Chen; Husseini K Manji; Valerie W Hu
Journal:  Genome Med       Date:  2010-04-07       Impact factor: 11.117

10.  Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy.

Authors:  Hongqing Du; Melissa S Cline; Robert J Osborne; Daniel L Tuttle; Tyson A Clark; John Paul Donohue; Megan P Hall; Lily Shiue; Maurice S Swanson; Charles A Thornton; Manuel Ares
Journal:  Nat Struct Mol Biol       Date:  2010-01-24       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.